We are live on
!
Find out more
New York State Common Retirement Fund Portfolio holdings
AUM
$79.3B
1-Year Est. Return
43.63%
This Fund
S&P 500
This Quarter
Est. Return
-14.97%
1 Year Est. Return
+43.63%
3 Year Est. Return
+132.82%
5 Year Est. Return
+173.87%
10 Year Est. Return
+697.67%
AUM
$76.6B
AUM Growth
-$16.9B
(-18%)
Cap. Flow
-$974M
Cap. Flow
% of AUM
-1.27%
Top 10 Holdings %
Top 10 Hldgs %
22.59%
Holding
3,645
New
297
Increased
1,013
Reduced
2,105
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$263M |
| 2 |
ConocoPhillips
COP
|
+$84.8M |
| 3 |
Airbnb
ABNB
|
+$84.6M |
| 4 |
Chevron
CVX
|
+$59.4M |
| 5 |
Salesforce
CRM
|
+$56.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$142M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$112M |
| 3 |
AT&T
T
|
+$94.5M |
| 4 |
UnitedHealth
UNH
|
+$79M |
| 5 |
NXP Semiconductors
NXPI
|
+$77.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 15.99% |
| 3 | Financials | 13.43% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Industrials | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Mustang Bio
MBIO
$4.55M
| $0 | ﹤0.01% |
1
-36
| -97% | -$19.9K |
|
3452
Neurogene
NGNE
$712M
| $0 | ﹤0.01% |
15
-705
| -98% | -$17.2K |
|
3453
Neuropace
NPCE
$506M
| $0 | ﹤0.01% |
66
-6,000
| -99% | -$39.6K |
|
|
OTRK
3454
DELISTED
Ontrak
OTRK
| $0 | ﹤0.01% |
1
-79
| -99% | -$11.1K |
|
3455
Pulse Biosciences
PLSE
$3.02B
| $0 | ﹤0.01% |
117
-9,900
| -99% | -$24.9K |
|
3456
Prelude Therapeutics
PRLD
$390M
| $0 | ﹤0.01% |
92
-4,900
| -98% | -$24.9K |
|
|
ALP
3457
Alpha Compute
ALP
$4.51M
| $0 | ﹤0.01% |
2
-195
| -99% | -$28.5K |
|
3458
Pyxis Oncology
PYXS
$236M
| $0 | ﹤0.01% |
108
-6,277
| -98% | -$16.7K |
|
3459
Quince Therapeutics
QNCX
$29.5M
| $0 | ﹤0.01% |
1
-71
| -99% | -$50.2K |
|
3460
Rekor Systems
REKR
$91.7M
| $0 | ﹤0.01% |
282
-14,300
| -98% | -$40.8K |
|
3461
Rafael Holdings
RFL
$107M
| $0 | ﹤0.01% |
107
-8,406
| -99% | -$16.7K |
|
3462
Regis Corp
RGS
$70.2M
| $0 | ﹤0.01% |
19
-870
| -98% | -$19.6K |
|
|
RTB
3463
RTB Digital
RTB
$232M
| – | – |
-35
| Closed | -$33.7K |
|
3464
Sera Prognostics
SERA
$81.1M
| – | – |
-7,140
| Closed | -$27K |
|
3465
ProShares Short S&P500
SH
$843M
| – | – |
-187,557
| Closed | -$10.6M |
|
3466
Solid Biosciences
SLDB
$900M
| $0 | ﹤0.01% |
33
-1,466
| -98% | -$15.2K |
|
3467
Summit Therapeutics
SMMT
$11.1B
| $0 | ﹤0.01% |
217
-14,600
| -99% | -$20.5K |
|
|
FTH
3468
Faeth Therapeutics
FTH
$629M
| $0 | ﹤0.01% |
8
-267
| -97% | -$10K |
|
|
SOPA
3469
DELISTED
Society Pass
SOPA
| – | – |
-847
| Closed | -$38K |
|
3470
Spero Therapeutics
SPRO
$73M
| $0 | ﹤0.01% |
223
-16,900
| -99% | -$49.1K |
|
3471
Spyre Therapeutics
SYRE
$9.25B
| $0 | ﹤0.01% |
14
-668
| -98% | -$23.4K |
|
3472
TE Connectivity
TEL
$62.6B
| – | – |
-237,112
| Closed | -$31.1M |
|
|
TERN
3473
DELISTED
Terns Pharmaceuticals
TERN
| $0 | ﹤0.01% |
118
-5,800
| -98% | -$11.6K |
|
3474
Team
TISI
$77.7M
| $0 | ﹤0.01% |
22
-2,060
| -99% | -$28.4K |
|
3475
Tonix Pharmaceuticals
TNXP
$192M
| – | – |
0
| – | – |
|
Similar funds
CBU
New York State Common Retirement Fund's Q2 2022 Portfolio in Review
As of Q2 2022, New York State Common Retirement Fund held 3,645 positions worth $76.6B, down 18% from $93.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
New York State Common Retirement Fund's Q2 2022 filing shows 297 new, 1,013 increased, 2,105 reduced and 75 closed positions. Its largest new stake was Gerdau: 4,099,701 shares worth $14M. The largest sale was Apple, an estimated $142M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- New York State Common Retirement Fund's largest Q2 2022 buy was Gerdau: 4,099,701 shares worth $14M.
- New York State Common Retirement Fund added most to Linde in Q2 2022, an estimated $263M increase.
- New York State Common Retirement Fund's biggest Q2 2022 reduction was Apple, cutting an estimated $142M.
- New York State Common Retirement Fund fully exited Anaplan, Inc. in Q2 2022, selling an estimated $53.5M.
- New York State Common Retirement Fund's ten largest holdings make up 23% of its $76.6B portfolio in Q2 2022.
- New York State Common Retirement Fund opened 297 new positions and closed 75 in Q2 2022.
- New York State Common Retirement Fund's portfolio value fell 18% quarter-over-quarter to $76.6B.
Based on New York State Common Retirement Fund's 13F filing for Q2 2022, filed 4 Aug 2022.